September 27, 2022 Comments Off on New patent for Astrazeneca drug LYNPARZA Posted in: Patent Added Annual Drug Patent Expirations for LYNPARZA Lynparza is a drug marketed by Astrazeneca and is included in two NDAs. It is available from one supplier. There are eleven patents protecting…
The post New patent for Astrazeneca drug LYNPARZA appeared first…
September 27, 2022 Comments Off on New patent for Avid Radiopharms drug TAUVID Posted in: Patent Added Annual Drug Patent Expirations for TAUVID Tauvid is a drug marketed by Avid Radiopharms Inc and is included in one NDA. It is available from one supplier. There is one…
The post New patent for Avid Radiopharms drug TAUVID appeared first on DrugPatentWa…
